Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 19, 2004

Hypertension. 2004
Published online before print January 19, 2004, doi: 10.1161/01.HYP.0000114601.30306.bf
A more recent version of this article appeared on March 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/3/654    most recent
01.HYP.0000114601.30306.bfv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, C.
Right arrow Articles by Jose, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, C.
Right arrow Articles by Jose, P. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Other Vascular biology

Submitted on September 2, 2003
Revised on September 30, 2003

Aberrant D1 and D3 Dopamine Receptor Transregulation in Hypertension

Chunyu Zeng*; Dan Wang; Laureano D. Asico; William J. Welch; Christopher S. Wilcox; Ulrich Hopfer; Gilbert M. Eisner; Robin A. Felder; and Pedro A. Jose

From the Departments of Pediatrics (C.Z., L.D.A., G.M.E., P.A.J.), Physiology and Biophysics (P.A.J.), and Internal Medicine (G.M.E.) and Division of Nephrology and Hypertension and Center for Hypertension and Renal Disease Research (D.W., W.J.W., C.S.W.), Georgetown University Medical Center, Washington, DC; Department of Physiology (U.H.), Case Western Reserve School of Medicine, Cleveland, Oh; Department of Pathology (R.A.F.), Virginia University for the Health Sciences, Charlottesville; and Department of Cardiology (C.Z.), Daping Hospital, Third Military Medical University, Chongqing, People’s Republic of China.

* To whom correspondence should be addressed. E-mail: cyzeng1{at}hotmail.com.

Abstract--Dopamine plays a role in the regulation of blood pressure by inhibition of sodium transport in renal proximal tubules (RPTs) and relaxation of vascular smooth muscles. Because dopamine receptors can regulate and interact with each other, we studied the interaction of D1 and D3 receptors in immortalized RPT cells and mesenteric arteries from Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHRs), and in human coronary artery smooth muscle cells (CASMCs). In WKY rats, the D1-like agonist, fenoldopam, increased D3 receptor protein in a time-dependent and concentration-dependent manner (EC50=4.5x10-9 M, t1/2=15.8 hours). In SHRs, fenoldopam (10-5 M) actually decreased the expression of D3 receptors. D1 and D3 receptor co-immunoprecipitation was increased by fenoldopam (10-7 M/24 h) in WKY rats but not in SHRs. The effects of fenoldopam in CASMCs were similar as those in WKY RPT cells (ie, fenoldopam increased D1 and D3 receptor proteins). Both D3 (PD128907, Emax=80%±6%, pED50=5±0.1) and D1-like receptor (fenoldopam, Emax=81%±8%, pED50=5±0.2, n=12) agonists relaxed mesenteric arterial rings. Co-stimulation of D1 and D3 receptors led to additive vasorelaxation in WKY rats, but not in SHRs. D1 and D3 receptors interact differently in WKY and SHRs. Altered interactions between D1 and D3 receptors may play a role in the pathogenesis of genetic hypertension, including human hypertension, because these receptors also interact in human vascular smooth muscle cells.


Key words: receptors • dopamine • rats • hypertension • normotension • kidney • vascular smooth muscle




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Zeng, Y. Liu, Z. Wang, D. He, L. Huang, P. Yu, S. Zheng, J. E. Jones, L. D. Asico, U. Hopfer, et al.
Activation of D3 Dopamine Receptor Decreases Angiotensin II Type 1 Receptor Expression in Rat Renal Proximal Tubule Cells
Circ. Res., September 1, 2006; 99(5): 494 - 500.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. Zeng, Z. Wang, H. Li, P. Yu, S. Zheng, L. Wu, L. D. Asico, U. Hopfer, G. M. Eisner, R. A. Felder, et al.
D3 Dopamine Receptor Directly Interacts With D1 Dopamine Receptor in Immortalized Renal Proximal Tubule Cells
Hypertension, March 1, 2006; 47(3): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. M. Bertorello and J. I. Sznajder
The Dopamine Paradox in Lung and Kidney Epithelia: Sharing the Same Target but Operating Different Signaling Networks
Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 432 - 437.
[Abstract] [Full Text] [PDF]